NIH Renews Nanomedicine Center Focused on Treating Single-Gene Disorders for $16M
Thursday, October 28, 2010 - 10:30
in Health & Medicine
The Georgia Tech-led Nanomedicine Center for Nucleoprotein Machines was renewed by NIH for $16.1M. The research team plans to pursue development of a clinically viable gene correction technology for single-gene disorders and demonstrate the technology's efficacy with sickle cell disease.